HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Placebo Causes Adverse Reaction With Industry, Raises Regulatory Concerns

This article was originally published in The Tan Sheet

Executive Summary

An inert sugar pill marketed as a placebo for ailing children will likely attract regulatory interest from the Federal Trade Commission as well as FDA, according to industry experts

You may also be interested in...



Pediatric CVD Report Slights Nutrition’s Role, Weighs On OTC Statin Chances

An American Academy of Pediatrics report recommending prescribing statin drugs for cardiovascular disease in children could present another roadblock for switching statins to OTC

CRN, DSEA Media Campaigns Separate But Together; Is Two Better Than One?

In late 2006, the Council for Responsible Nutrition and the Dietary Supplement Education Alliance both shared plans for media campaigns aimed at building consumer confidence in the supplement industry

Qualified Health Claims In “More Unified, Informative” Format Urged By CRN

The "good news, bad news" format FDA has adopted for qualified health claims seems "unlikely to provide consumers with a good understanding of the nature of the support that exists for the statement or the reasons for FDA's unfavorable view of the claim," according to the Council for Responsible Nutrition

Related Content

Topics

UsernamePublicRestriction

Register

RS137300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel